T3D Therapeutics, Inc.
3 clinical trials · Sponsor
◉ Watch T3D Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| A Phase 2b/3 Clinical Study Evaluating T3D-959 in Mild-to-Moderate Alzheimer's Disease Subjects (NCT06964230) | T3D Therapeutics, Inc. | 2026-10-26 |
| Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate AD Subjects (NCT04251182) | T3D Therapeutics, Inc. | 2021-03-01 |
Track T3D Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.